An AI tool appeared superior to two FDA-approved biomarkers for predicting how people with cancer will respond to immune ...
Northwestern Medicine investigators have developed a new avenue to reprogram compromised immune cells to act against tumors, ...
The following is a summary of “Antibiotics use decreases survival in cutaneous squamous cell carcinoma patients receiving immune checkpoint inhibitors,” published in the January 2025 issue of Oncology ...
Niraparib in patients with BRCA-mutated unresectable or recurrent biliary tract, pancreatic and other gastrointestinal cancers: An investigator-initiated phase 2 trial (NIR-B trial). This is an ASCO ...
Cancer treatments like immune checkpoint blockade, for example, can trigger autoimmunity. Similarly, drugs targeting ...
News Medical on MSN9d
Microbes in your gut could determine cancer treatment outcomesResearchers reveal that gut microbiota influence the effectiveness of immune checkpoint inhibitors (ICIs) in cancer treatment ...
Biological and therapeutic impact of tumor mutational burden in microsatellite instability/mismatch repair-deficient (MSI/dMMR) metastatic colorectal cancer (mCRC) treated with immune checkpoint ...
2 These proteins turn off the immune system and prevent it from killing cancer ... The dual checkpoint blockades also demonstrated that CTLA-4 checkpoint blockade maintained a pool of progenitor T ...
Priya Hays, Hays Documentation Specialists, discusses innovations and advancements in the development of personalized cancer ...
New research highlights the potential of the novel diagnostic tool iFRET to determine immunotherapy outcomes in stage 2 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback